Vcanbio Cell&Gene Engineering Corp.,Ltd’s Net Profit Dropped 29.4% in 2022

Vcanbio Cell&Gene Engineering Corp.,Ltd (中源协和细胞基因工程股份有限公司) (600645.SH) reported a net profit of 106.7 million yuan in 2022, down 29.4% year-on-year.

Meanwhile, the company posted 1.6 billion yuan in revenue, up 1.3% year-on-year.

At the end of the reporting period, it had 5.3 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 30.9%.